Literature DB >> 29128164

Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.

Emma M Coppen1, Milou Jacobs2, Annette A van den Berg-Huysmans3, Jeroen van der Grond4, Raymund A C Roos5.   

Abstract

BACKGROUND: Motor disturbances are clinical hallmarks of Huntington's disease (HD) and involve chorea, dystonia, hypokinesia and visuomotor dysfunction. Investigating the association between specific motor signs and different regional volumes is important to understand the heterogeneity of HD.
OBJECTIVE: To investigate the motor phenotype of HD and associations with subcortical and cortical grey matter volume loss.
METHODS: Structural T1-weighted MRI scans of 79 HD patients and 30 healthy controls were used to calculate volumes of seven subcortical structures including the nucleus accumbens, hippocampus, thalamus, caudate nucleus, putamen, pallidum and amygdala. Multiple linear regression analyses, corrected for age, gender, CAG, MRI scan protocol and normalized brain volume, were performed to assess the relationship between subcortical volumes and different motor subdomains (i.e. eye movements, chorea, dystonia, hypokinesia/rigidity and gait/balance). Voxel-based morphometry analysis was used to investigate the relationship between cortical volume changes and motor signs.
RESULTS: Subcortical volume loss of the accumbens nucleus, caudate nucleus, putamen, and pallidum were associated with higher chorea scores. No other subcortical region was significantly associated with motor symptoms after correction for multiple comparisons. Voxel-based cortical grey matter volume reductions in occipital regions were related with an increase in eye movement scores.
CONCLUSION: In HD, chorea is mainly associated with subcortical volume loss, while eye movements are more related to cortical volume loss. Both subcortical and cortical degeneration has an impact on motor impairment in HD. This implies that there is a widespread contribution of different brain regions resulting in the clinical motor presentation seen in HD patients.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Basal ganglia; Chorea; Huntington's disease; Motor cortex; Structural MRI

Mesh:

Year:  2017        PMID: 29128164     DOI: 10.1016/j.parkreldis.2017.11.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  11 in total

1.  Restoration of BDNF, DARPP32, and D2R Expression Following Intravenous Infusion of Human Immature Dental Pulp Stem Cells in Huntington's Disease 3-NP Rat Model.

Authors:  Cristiane Valverde Wenceslau; Dener Madeiro de Souza; Nicole Caroline Mambelli-Lisboa; Leandro Hideki Ynoue; Rodrigo Pinheiro Araldi; Joyce Macedo da Silva; Eduardo Pagani; Monica Santoro Haddad; Irina Kerkis
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

2.  Temporal Characterization of Behavioral and Hippocampal Dysfunction in the YAC128 Mouse Model of Huntington's Disease.

Authors:  Cristine de Paula Nascimento-Castro; Elisa C Winkelmann-Duarte; Gianni Mancini; Priscilla Gomes Welter; Evelini Plácido; Marcelo Farina; Joana Gil-Mohapel; Ana Lúcia S Rodrigues; Andreza Fabro de Bem; Patricia S Brocardo
Journal:  Biomedicines       Date:  2022-06-17

3.  Atrophy of the putamen at time of clinical motor onset in Huntington's disease: a 6-year follow-up study.

Authors:  Emma M Coppen; Jeroen van der Grond; Raymund A C Roos
Journal:  J Clin Mov Disord       Date:  2018-03-23

4.  Accuracy of automated amygdala MRI segmentation approaches in Huntington's disease in the IMAGE-HD cohort.

Authors:  Bonnie Alexander; Nellie Georgiou-Karistianis; Richard Beare; Lotta M Ahveninen; Valentina Lorenzetti; Julie C Stout; Yifat Glikmann-Johnston
Journal:  Hum Brain Mapp       Date:  2020-02-07       Impact factor: 5.038

5.  Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington's disease.

Authors:  Maria Del C Valdés Hernández; Janna Abu-Hussain; Xinyi Qiu; Josef Priller; Mario Parra Rodríguez; Mariana Pino; Sandra Báez; Agustín Ibáñez
Journal:  Brain Behav       Date:  2019-07-05       Impact factor: 2.708

6.  The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease.

Authors:  Rachel Y Cheong; Sanaz Gabery; Åsa Petersén
Journal:  J Huntingtons Dis       Date:  2019

7.  Exploration of a Co-Production Approach to Developing a Walking Group with People with Huntington's Disease.

Authors:  Una Jones; Katy Hamana; Sofia Vougioukalou; Mel Jones; Monica Busse
Journal:  Med One       Date:  2019-10-31

8.  The development of PAT-HD: A co-designed tool to promote physical activity in people with Huntington's disease.

Authors:  Una Jones; Katy Hamana; Fran O'Hara; Monica Busse
Journal:  Health Expect       Date:  2021-02-13       Impact factor: 3.318

9.  The neuroimaging magnitude of pediatric brain atrophy in northern Tanzania.

Authors:  Richard Erasto Sungura; John Martin Spitsbergen; Emmanuel Abraham Mpolya; Elingarami Sauli; John-Mary Vianney
Journal:  Pan Afr Med J       Date:  2020-05-21

10.  Emerging differences between Huntington's disease-like 2 and Huntington's disease: A comparison using MRI brain volumetry.

Authors:  David G Anderson; Mark Haagensen; Aline Ferreira-Correia; Ronald Pierson; Jonathan Carr; Amanda Krause; Russell L Margolis
Journal:  Neuroimage Clin       Date:  2019-01-07       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.